Efficacité du traitement de reperfusion au stade aigu de l'infarctus dans la population âgée : données du registre USIK 1995

@article{Demichli2002EfficacitDT,
  title={Efficacit{\'e} du traitement de reperfusion au stade aigu de l'infarctus dans la population {\^a}g{\'e}e : donn{\'e}es du registre USIK 1995},
  author={T Demich{\'e}li and J. P. Cambou and Laurent Vaur and N. Gen{\`e}s and Sylvie Etienne and Micha{\"e}l Angioi and Nicolas Danchin},
  journal={Annales De Cardiologie Et D Angeiologie},
  year={2002},
  volume={51},
  pages={20-24}
}
View via Publisher
9 Citations

9 Citations

Citation Type

Citation Type

Évolution de la prise en charge et du pronostic de l'infarctus du myocarde en France entre 1995 et 2000 : résultats des études USIK 1995 et USIC 2000
Évaluation de la prise en charge de l'infarctus du myocarde dans la région Provence-Alpes-Côte d'Azur
Prise en charge par le Samu de l'infarctus du myocarde avec sus-décalage du segment ST en milieu urbain chez le sujet âgé de plus de 80 ans
L'infarctus du sujet âgé : données du registre FAST-MI 2010
Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000 : données des études Usik 1995, Prévenir 1 et 2 et Usic 2000
Percutaneous Coronary Interventional Therapy in the 9th Decade of Life
TLDR
There is a report of percutaneous coronary intervention (PCI) in 12 cases of coronary artery disease among nonagenarians, and the author claims to be the first 1 to report PCI in this age group, and also notes very few reports in the literature.
Prise en charge thérapeutique de l'insuffisance cardiaque et de la dysfonction ventriculaire gauche post-infarctus du myocarde dans les unités de soins intensifs en cardiologie française
Valeur du délai « porte-ballon » pour évaluer l’efficacité de la stratégie interventionnelle de reperfusion à la phase aiguë de l’infarctus du myocarde avec sus-décalage du segment ST
Les registres : pour quoi faire ?: L’exemple des syndromes coronaires aigus

References

SHOWING 1-10 OF 12 REFERENCES
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
TLDR
Lower mortality and greater net clinical benefit were seen with accelerated TPA in patients aged < or = 85 years, and the relative superiority of a given thrombolytic regimen cannot be determined.
Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results.
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.
TLDR
In nationwide clinical practice, thrombolytic therapy for patients >75 years old is unlikely to confer survival benefit and may have a significant survival disadvantage.
MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction
A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
TLDR
This trial suggests that angioplasty provides a small-to-moderate, short-term clinical advantage over thrombolytic therapy with t-PA, and should be considered an excellent alternative method for myocardial reperfusion.
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
TLDR
As compared with t-PA therapy for acute myocardial infarction, immediate PTCA reduced the combined occurrence of nonfatal reinfarction or death, was associated with a lower rate of intracranial hemorrhage, and resulted in similar left ventricular systolic function.
Twenty-five—year mortality rate decrease in patients in Israel with a first episode of acute myocardial infarction
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
TLDR
The findings of this large-scale trial indicate that accelerated t-PA given with intravenous heparin provides a survival benefit over previous standard thrombolytic regimens.
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.
TLDR
Immediate angioplasty after acute myocardial infarction was associated with a higher rate of patency of the infarct-related artery, a less severe residual stenotic lesion, better left ventricular function, and less recurrentMyocardial ischemia andinfarction than was intravenous streptokinase.
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review
TLDR
Based on outcomes at hospital discharge or 30 days, primary angioplasty appears to be superior to thrombolytic therapy for treatment of patients with acute myocardial infarction, with the proviso that success rates for angiopLasty are as good as those achieved in these trials.
...
1
2
...